OptimizeRx Reports First Quarter 2020 Results; Revenue Up 46% to a Record $7.6 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- European shares subdued as surging crude sharpens focus on ECB rate path
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Optimizerx Corporation (OPRX) Misses Q1 EPS by 3c, Revenues Beat
May 4, 2020 4:40 PM EDTOptimizerx Corporation (NASDAQ: OPRX) reported Q1 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $6.89 million.
Q1 2020 Financial Highlights
Total year over year revenue increased 46% to a record $7.6 million.Year over year gross profit increased 20% to $4.3 million.Cash and cash equivalents totaled $15.2 million at March 31, 2020.Q1 2020 Operational Highlights
Secured several multi-million-dollar enterprise-level engagements for access to OptimizeRxs fully integrated communications platform, further transitioning the company to a recurring revenue model. OptimizeRx Innovation Lab launched... More